What a clinical embryologist actually does
A clinical embryologist is a laboratory scientist responsible for human gametes (the eggs, or oocytes, and sperm) and for the embryos created from them. In an IVF programme (IVF stands for in vitro fertilisation, literally fertilisation "in glass", meaning outside the body), the embryologist is the person who receives the eggs after they are collected, brings them together with sperm, keeps the resulting embryos alive for several days, judges how they are developing, hands the chosen one back for transfer into the uterus, and freezes the rest for later use.
A working day usually follows the theatre list. Fluid aspirated from a woman's ovarian follicles arrives in the laboratory within seconds, and the embryologist searches it under a stereomicroscope for eggs that are invisible to the naked eye. The semen sample is prepared in parallel, separating motile sperm from the rest of the ejaculate. Fertilisation is then attempted either by conventional insemination, which means placing prepared sperm around each egg in a dish, or by ICSI (intracytoplasmic sperm injection), in which a single immobilised sperm is injected directly into an egg using a glass needle under a high-magnification microscope. The dishes go into an incubator that holds temperature and gas composition close to conditions inside the body. Fertilisation is confirmed the next morning; development is then assessed over the following days, often to the blastocyst stage: a hollow ball of roughly a hundred or more cells, reached around day five or six, at which point the embryo would normally be arriving in the uterus.
The same person is usually responsible for andrology, the laboratory side of male fertility: semen analysis (measuring sperm number, movement and shape against defined criteria), preparation of samples for treatment, handling of sperm recovered surgically from the testis or epididymis when none is present in the ejaculate, and freezing of sperm for storage. Embryologists also perform vitrification and the warming procedure that reverses it. Vitrification is an ultra-rapid form of freezing that turns cells into a glass-like state without forming ice crystals, and it is now the standard method for storing eggs and embryos.
Much of the job never involves a microscope. Labelling, double-checking identities, recording what was done to which patient's material and when, calibrating and monitoring equipment, logging incubator temperatures and gas levels, checking culture media (the nutrient fluids embryos live in) against expiry and storage records, maintaining the freezing inventory so that a straw of embryos placed in liquid nitrogen years ago can be located with certainty: that is the bulk of the work. This administrative discipline is not bureaucracy attached to the science; in an IVF laboratory it is the science.
Embryologist and fertility doctor: two different jobs
The fertility doctor, in most settings a gynaecologist with additional training in reproductive medicine, is responsible for the patient. That means taking the history, investigating the causes of infertility, deciding whether treatment is appropriate and which kind, prescribing and adjusting the drugs that stimulate the ovaries, monitoring the response by ultrasound and blood tests, performing the egg collection, placing the embryo in the uterus, and providing care and follow-up afterwards. Every decision that involves a person's body, health risk or consent belongs to the clinician.
The embryologist is responsible for the cells. From the moment follicular fluid leaves the operating theatre until an embryo is returned for transfer or placed into storage, everything that happens to the gametes and embryos is the laboratory's work and the laboratory's accountability. These are two different bodies of training with almost no overlap: a reproductive medicine specialist is not trained to perform ICSI or vitrification, and an embryologist is not qualified to prescribe, to scan or to advise a patient on treatment. Neither can substitute for the other, and an IVF unit is only as good as the weaker of the two.
Some decisions are shared. Which embryo to transfer, and how many, is a discussion in which the embryologist contributes what the laboratory observed, such as whether fertilisation was normal, how the embryos developed and what their appearance under the microscope suggests, while the clinician weighs the patient's age, medical history and the risks of a multiple pregnancy, and the patient gives informed consent. Patients frequently never meet the embryologist, which is a matter of workflow rather than secrecy. It is entirely reasonable to ask a clinic who runs its laboratory, what their training is, and how many embryologists are on the team.
Why the laboratory sets the ceiling
An IVF embryo spends its first days of existence outside the body. During that period nothing regulates it: temperature, acidity, the concentration of salts and sugars in the fluid around it, the mixture of gases above it, the light it is exposed to, and every plastic and glass surface it touches are all supplied by the laboratory. An embryo has no capacity to complain and very little capacity to recover. Whatever the laboratory provides is what it gets.
The margins are narrow, and this is where the discipline of the field comes from rather than from any single clever technique. Culture medium becomes more alkaline within minutes of a dish leaving a carbon-dioxide incubator, which is why experienced embryologists work fast and keep dishes covered and warmed. A microscope stage a couple of degrees below body temperature can disturb the delicate scaffolding inside an egg. Volatile organic compounds are a recognised hazard to embryo development in the assisted reproduction literature, whether they come from fresh paint, adhesives, cleaning products, new furniture, perfume or vehicle exhaust drawn in from outside. That is why air handling in an IVF laboratory is treated as clinical equipment rather than as building services.
The same patient, with the same drugs and the same clinician, does not have the same treatment in two different laboratories. Better stimulation cannot compensate for an unstable incubator, and no drug protocol repairs an embryo that has been chilled or exposed to a contaminated air supply. The human element carries the same weight: identical protocols in different hands give different results, which is why competent laboratories assess the skill of each individual embryologist rather than the laboratory as an anonymous whole.
There is a second, blunter category of laboratory failure: identifying the wrong material. Eggs, sperm and embryos from different patients look alike, cannot be distinguished after the fact by eye, and cannot be un-mixed. A mix-up is irreversible and life-altering, and it is the reason that serious laboratories require a second person, or a validated electronic system, to witness and record every step at which patient material moves between one container and another.
What a well-run ART laboratory maintains
ART stands for assisted reproductive technology: IVF, ICSI, freezing and the procedures around them. The clearest marker of a well-run ART laboratory is a functioning quality management system: written step-by-step procedures that staff actually follow, documented training and periodic reassessment of each person's competence, a register of equipment and its servicing, internal audit, and an honest incident log in which near-misses are recorded and acted on rather than quietly forgotten. Professional bodies including ESHRE (the European Society of Human Reproduction and Embryology) and, in the United States, ASRM publish guidance for good practice in IVF laboratories; these documents are freely available and are the reference point that responsible laboratories anywhere in the world work towards.
Physically, that translates into control of the environment and of equipment: filtered air supplied to the laboratory under slight positive pressure so that unfiltered air cannot leak in, materials and cleaning agents chosen for low chemical emission, incubators and refrigerators under continuous monitoring with alarms that reach a named person at three in the morning, calibrated thermometers and gas analysers checked against reference standards, an uninterrupted power supply, and secure liquid-nitrogen provision with the storage tanks themselves alarmed. Consumables that touch embryos (dishes, pipettes, media, oil) are batch-recorded and, where suppliers provide it, tested for embryo safety.
Traceability runs alongside all of this. Every dish, straw and tube carries identifiers that tie it to a named patient and partner; every transfer between vessels is witnessed; consent for storage and for use is documented and its currency checked before anything is thawed or transferred. In a properly run unit it is possible to reconstruct, years later, exactly what happened to a particular embryo, who handled it, in which incubator, and under whose consent.
Finally, a serious laboratory measures itself. ESHRE and Alpha Scientists in Reproductive Medicine published a consensus set of laboratory performance indicators: figures such as the proportion of eggs that fertilise normally after ICSI, the proportion of embryos reaching the blastocyst stage, and survival after freezing and warming. Each carries a minimum "competency" value a laboratory should be able to meet and a higher "benchmark" value to aim at, so that falling below competency is the signal to investigate. The purpose of tracking these is internal: they are early-warning instruments that reveal a drifting incubator, a bad batch of medium or a technique problem long before anyone could infer it from pregnancy figures. They are not marketing material, and a laboratory that quotes performance numbers to patients while unable to explain how it monitors them is showing the wrong thing.
The state of the field in Nepal
Assisted reproduction is now established in Nepal. Provision is concentrated in the Kathmandu Valley, with services also developing in other cities, and the number of centres offering IVF has grown noticeably over the past decade. For many years couples who wanted IVF commonly travelled to India, which added cost, time away from work and the difficulty of managing a treatment cycle in another country; a growing proportion of that care can now be obtained domestically. Demand is not in question. Infertility affects a broadly similar share of couples everywhere, and the constraint in Nepal has been the availability of trained people and properly equipped laboratories rather than the number of patients.
Training is the tighter constraint of the two. I am not aware of any Nepali university that awards a dedicated clinical embryology degree, and I could find none listed when I looked; people therefore enter the field from biotechnology, microbiology, zoology or related life-science degrees and obtain their specialist embryology training abroad, most often in India, where dedicated M.Sc. and fellowship programmes admit students from Nepal. My own route was that one: an M.Sc. in Biotechnology from Tribhuvan University, followed by an M.Sc. in Clinical Embryology at SEART/Shridhar University from 2023 to 2025, where I finished in first position with the highest CGPA in the programme and was awarded the gold medal. Anyone considering this career in Nepal today should expect to spend a period outside the country to acquire the practical training.
Because the specialist workforce is small, laboratory cover is thin: a number of centres in Nepal have no embryologist of their own on site and depend on one who comes in when needed, and some run IVF only in batches for that reason. This has consequences that patients rarely see. A single-handed laboratory has no cover for illness, leave or resignation; it has no colleague to witness critical steps or to give a second opinion on a difficult embryo assessment; and the knowledge of how that particular laboratory works exists in one person's head rather than in a documented system. More trained embryologists, written procedures and cross-cover between staff matter at least as much as buying newer equipment.
The regulatory picture is still taking shape, and it changed materially in 2025. Nepal's Right to Safe Motherhood and Reproductive Health Act, 2075 (2018) is the governing reproductive health statute, but it says nothing about IVF, ART or surrogacy: infertility appears in it only inside the definition of "morbidity", which carries a right to examination, counselling and treatment at a health institution. Surrogacy has no enacted statute at all. The Supreme Court suspended commercial surrogacy in 2015 and ruled in 2016 that surrogacy should be available only on an altruistic basis to infertile Nepali married couples, and legislation to implement that ruling has still not been passed. What does now exist is administrative regulation by the Ministry of Health and Food Safety: under the Standard for the Operation of Infertility Management Services (IVF), 2082, endorsed in August 2025 under the ministry as it was then constituted, a health facility must obtain the Ministry's prior permission before offering IUI or IVF, must employ trained embryologists and other specified staff, and must meet stated laboratory and infrastructure requirements, with licensed centres subject to inspection and periodic renewal. What Nepal still lacks is primary ART legislation and a dedicated statutory authority of the kind the United Kingdom's Human Fertilisation and Embryology Authority represents; as reported in the press, at a ministerial-level meeting in July 2026 the ministry decided to draft an operating procedure for IVF services and to pursue a separate ART Act. A statutory register for the profession does exist: the Nepal Health Professional Council keeps one under the Nepal Health Professional Council Act, 2053, and it recognises M.Sc. Medical/Clinical Embryology, but nothing links that registration to a laboratory's licence and the register cannot be searched publicly, so a centre's licence does not in practice depend on who actually handles the embryos. Because the framework is new and rests on ministerial standards rather than a settled statute, readers should check the current rules rather than rely on a summary. In practice the standard of a laboratory still depends heavily on the professionalism of the people running that particular centre, which is why the questions patients ask about the laboratory carry weight.
How the field is likely to develop in Nepal
The most predictable development is pressure on training. If centres continue to open while specialist training remains something to be acquired abroad, demand for embryologists will outrun the supply of properly trained ones, and the risk is that laboratories are staffed by people who have watched the work rather than been trained in it. The constructive response is a structured domestic training pathway: university teaching linked to supervised practice in working laboratories, with assessment of practical competence rather than only written examination. Alongside it, a professional association through which embryologists in Nepal can set expectations for each other. Neither requires new legislation to begin.
Technology will keep arriving, and it should be understood in the right order. Vitrification is already the standard method internationally for freezing eggs and embryos. Time-lapse incubators, which photograph embryos at intervals so they can be assessed without being removed from a stable environment, are increasingly common internationally. Preimplantation genetic testing, or PGT, which means removing a few cells from a blastocyst and having them analysed in a genetics laboratory, is available in the region and is used for specific indications rather than routinely. Software that scores embryo images, sometimes described as artificial intelligence, is an active research area whose place in routine practice is still being defined. All of these are additions on top of controlled temperature, clean air and disciplined technique. A laboratory that has not secured the basics gains little from equipment that measures its embryos more precisely.
The change that would do most for patients is unglamorous: measurement and transparency. Where countries collect treatment cycles and outcomes in a national registry, individual units can compare themselves against a real national picture instead of against impressions, poor performance becomes visible early, and public discussion of IVF can rest on data rather than on advertising. Alongside that, voluntary accreditation of laboratories against published international guidance would give centres that invest in doing the work properly a way to demonstrate it, and would give patients something more substantial than a brochure to judge.
For students weighing the field, it is worth being clear about the nature of the work. It is precise, repetitive and physically demanding on the hands and eyes; it runs on weekends and public holidays because embryos do not pause; and it carries consequences that cannot be undone by a second attempt. What it asks for is manual steadiness, patience, a temperament suited to checking things twice, and a willingness to keep reading the literature for the whole of a career. It is a good career for someone who takes satisfaction in doing a small number of things extremely carefully, and a poor one for anyone who finds routine intolerable.